Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DiaMedica Therapeutics Inc. | 97,949 | reported | 02 Jan 2026 | tx 17+233,647−12,000 |
| ONCOLYTICS BIOTECH INC | 41,849 | reported | 11 Mar 2026 | tx 1+10,000 |
| Trillium Therapeutics Inc. | 0 | reported | 17 Nov 2021 | tx 11+8,505−478,395 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Mar 2026 | PURCHASE | ONCOLYTICS BIOTECH INC | 10,000 | 1.03 USD | first after silence |
| 02 Jan 2026 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 10,095 | 8.42 USD | |
| 21 Nov 2025 | EXERCISE | DiaMedica Therapeutics Inc. | 12,000 | 2.20 USD | |
| 21 Nov 2025 | EXERCISE | DiaMedica Therapeutics Inc. | 12,000 | 0.00 USD | deriv |
| 01 Jun 2025 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 40,739 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 15,917 | 5.34 USD | |
| 02 Jan 2025 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 4,287 | 0.00 USD | deriv |
| 01 Jun 2024 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 28,472 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 21,428 | 2.80 USD | |
| 01 Jun 2023 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 16,968 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 13,222 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 16,773 | 3.58 USD | |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 30,171 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 30,171 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 24,390 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 36,204 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 5,761 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 59,896 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 180,000 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 94,792 | 0.00 USD | deriv |
| 15 Jul 2021 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 9,393 | 0.00 USD | deriv |
| 08 Jan 2021 | SALE | Trillium Therapeutics Inc. | 8,505 | 15.79 USD | |
| 08 Jan 2021 | EXERCISE | Trillium Therapeutics Inc. | 8,505 | 7.24 USD | |
| 08 Jan 2021 | EXERCISE | Trillium Therapeutics Inc. | 8,505 | 0.00 USD | deriv |
| 01 Jan 2021 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 7,745 | 8.23 USD |
1 purchase reported after at least 12 months of silence — most recent on 11 Mar 2026.